Accelerating precision medicine in metastatic prostate cancer

Joaquı́n Mateo(Royal Marsden NHS Foundation Trust), Himisha Beltran(Dana-Farber Cancer Institute), Eric J. Small(CancerCare Manitoba), Jonathan W. Simons(Unknown), Felix Y. Feng(University of Michigan), William L. Dahut(National Cancer Institute), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Julie N. Graff(Oregon Health & Science University), Maha Hussain(Northwestern University), Ajjai Alva(Michigan Medicine), Matthew B. Rettig(University of Southern California), Jake Vinson(Memorial Sloan Kettering Cancer Center), Joshi J. Alumkal(University of Michigan), Bruce Montgomery(Fred Hutch Cancer Center), Rana R. McKay(University of California San Diego), Howard R. Soule(Prostate Cancer Foundation), Wassim Abida(Memorial Sloan Kettering Cancer Center), Fatima Karzai(National Institutes of Health), Vaibhav G. Patel(Arvinas (United States)), David James VanderWeele(Northwestern University), William Oh(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Rahul Aggarwal(UCSF Helen Diller Family Comprehensive Cancer Center), Xīn Gào(Qingdao University), David B. Solit(Memorial Sloan Kettering Cancer Center), Matthew R. Smith(Massachusetts General Hospital), Arul M. Chinnaiyan(Howard Hughes Medical Institute), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Andrea K. Miyahira(Prostate Cancer Foundation), Cora N. Sternberg(Cornell University)
Nature Cancer
November 17, 2020
Cited by 78


Related Papers